LASA SUPERGENERICS
|
The Current P/S Ratio of LASA SUPERGENERICS is 0.71.
Share Price | ₹17.9 | May 14,2025 |
Market Cap | ₹89.5 Cr | |
Sales-TTM | ₹126.1 Cr | TTM-Standalone Results |
Price/Sales | 0.71x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of LASA SUPERGENERICS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹89.5 Cr] as on May 14,2025
(/) Sales [ ₹126.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 0.71x ]
Thus, for LASA SUPERGENERICS , the investors are currently willing to pay '0.71 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LASA SUPERGENERICS !
The chart below summarizes the trend in P/S Ratio of LASA SUPERGENERICS over the last five years.
Historical PS (Price/Sales) ratio chart of LASA SUPERGENERICS
PS Ratio Performance Analysis for LASA SUPERGENERICS
- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.03x.
- LASA SUPERGENERICS 's operated at median p/e ratio of 1.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2022 at 1.52x.
- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2020 of 0.69x.
How does LASA SUPERGENERICS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
LASA SUPERGENERICS | 126.1 | 0.71 | 89.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.94 | 409,818.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 18.13 | 164,628.0 |
CIPLA LTD | 27,547.6 | 4.38 | 120,775.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.71 | 109,758.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.12 | 101,791.0 |
MANKIND PHARMA LTD | 11,641.0 | 9.04 | 105,255.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.09 | 90,963.5 |
LUPIN LTD | 22,001.6 | 4.30 | 94,611.0 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.29 | 70,834.6 |
ABBOTT INDIA LTD | 6,243.2 | 10.33 | 64,488.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LASA SUPERGENERICS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.71x |
Max industry PS | 18.13x |
Median industry PS | 4.38x |
Average industry PS | 6.73x |
You may also like the below Video Courses